Beximco Pharmaceuticals Ltd
From Wikipedia, the free encyclopedia
 |
This 13 November 2006 is written like an advertisement. Please help rewrite this article from a neutral point of view per Wikipedia policy. Mark blatant advertising for speedy deletion with {{db-spam}}. (help, talk) |
Beximco Pharmaceuticals Ltd, also known as Beximco Pharma is a major pharmaceutical company based in Bangladesh. It is part of the Beximco Group of Companies.
| Beximco Pharmaceuticals Ltd. Bangladesh | |
 |
|
| Type | Ltd |
|---|---|
| Founded | 1980 |
| Headquarters | Tongi, Dhaka, Bangladesh |
| Key people | Nazmul Hassan CEO |
| Industry | Pharmaceutical |
| Website | http://www.beximco-pharma.com/ |
Contents |
[edit] Corporate History
Beximco Pharma started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA. BP has now grown to become one of Bangladesh's leading pharmaceutical companies, supplying more than 10% of country's total medicine need. Today Beximco Pharma manufactures and markets its own `branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets.
[edit] Factories
Beximco Pharma manufacturing facilities are spread across a 20-acre site located in Dhaka, Bangladesh. The facilities comprise of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.
[edit] Business Information
The company's annual production exceeds $50 million. It employs over 1900.
